Literature DB >> 11906195

Cellular defense against UVB-induced phototoxicity by cytosolic NADP(+)-dependent isocitrate dehydrogenase.

Seung-Hee Jo1, So-Hyun Lee, Hang Suk Chun, Su Min Lee, Ho-Jin Koh, Sung-Eun Lee, Jang-Soo Chun, Jeen-Woo Park, Tae-Lin Huh.   

Abstract

Ultraviolet (UV) radiation is known as a major cause of skin photoaging and photocarcinogenesis. Many harmful effects of UV radiation are associated with the generation of reactive oxygen species. Recently, we have shown that NADP(+)-dependent isocitrate dehydrogenase is involved in the supply of NADPH needed for GSH production against cellular oxidative damage. In this study we investigated the role of cytosolic form of NADP(+)-dependent isocitrate dehydrogenase (IDPc) against UV radiation-induced cytotoxicity by comparing the relative degree of cellular responses in three different NIH3T3 cells with stable transfection with the cDNA for mouse IDPc in sense and antisense orientations, where IDPc activities were 2.3-fold higher and 39% lower, respectively, than that in the parental cells carrying the vector alone. Upon exposure to UVB (312 nm), the cells with low levels of IDPc became more sensitive to cell killing. Lipid peroxidation, protein oxidation, oxidative DNA damage, and intracellular peroxide generation were higher in the cell-line expressing the lower level of IDPc. However, the cells with the highly overexpressed IDPc exhibited enhanced resistance against UV radiation, compared to the control cells. The data indicate that IDPc plays an important role in cellular defense against UV radiation-induced oxidative injury. (c)2002 Elsevier Science (USA).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11906195     DOI: 10.1006/bbrc.2002.6667

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

1.  Cancer-Associated IDH1 Promotes Growth and Resistance to Targeted Therapies in the Absence of Mutation.

Authors:  Andrea E Calvert; Alexandra Chalastanis; Yongfei Wu; Lisa A Hurley; Fotini M Kouri; Yingtao Bi; Maureen Kachman; Jasmine L May; Elizabeth Bartom; Youjia Hua; Rama K Mishra; Gary E Schiltz; Oleksii Dubrovskyi; Andrew P Mazar; Marcus E Peter; Hongwu Zheng; C David James; Charles F Burant; Navdeep S Chandel; Ramana V Davuluri; Craig Horbinski; Alexander H Stegh
Journal:  Cell Rep       Date:  2017-05-30       Impact factor: 9.423

2.  Role of cytosolic NADP+-dependent isocitrate dehydrogenase in ischemia-reperfusion injury in mouse kidney.

Authors:  Jinu Kim; Ki Young Kim; Hee-Seong Jang; Takumi Yoshida; Ken Tsuchiya; Kosaku Nitta; Jeen-Woo Park; Joseph V Bonventre; Kwon Moo Park
Journal:  Am J Physiol Renal Physiol       Date:  2008-12-23

Review 3.  Isocitrate dehydrogenase mutations in gliomas.

Authors:  Matthew S Waitkus; Bill H Diplas; Hai Yan
Journal:  Neuro Oncol       Date:  2015-07-16       Impact factor: 13.029

Review 4.  Isocitrate dehydrogenase 1 and 2 mutations in cancer: alterations at a crossroads of cellular metabolism.

Authors:  Zachary J Reitman; Hai Yan
Journal:  J Natl Cancer Inst       Date:  2010-05-31       Impact factor: 11.816

5.  Proteomic and phosphoproteomic analysis of polyethylene glycol-induced osmotic stress in root tips of common bean (Phaseolus vulgaris L.).

Authors:  Zhong-Bao Yang; Dejene Eticha; Hendrik Führs; Dimitri Heintz; Daniel Ayoub; Alain Van Dorsselaer; Barbara Schlingmann; Idupulapati Madhusudana Rao; Hans-Peter Braun; Walter Johannes Horst
Journal:  J Exp Bot       Date:  2013-10-11       Impact factor: 6.992

Review 6.  Protein oxidation, UVA and human DNA repair.

Authors:  Peter Karran; Reto Brem
Journal:  DNA Repair (Amst)       Date:  2016-05-20

Review 7.  Isocitrate dehydrogenases in physiology and cancer: biochemical and molecular insight.

Authors:  Hamoud Al-Khallaf
Journal:  Cell Biosci       Date:  2017-08-03       Impact factor: 7.133

Review 8.  Metabolic adaptations in cancers expressing isocitrate dehydrogenase mutations.

Authors:  Ingvild Comfort Hvinden; Tom Cadoux-Hudson; Christopher J Schofield; James S O McCullagh
Journal:  Cell Rep Med       Date:  2021-12-21

Review 9.  What a difference a hydroxyl makes: mutant IDH, (R)-2-hydroxyglutarate, and cancer.

Authors:  Julie-Aurore Losman; William G Kaelin
Journal:  Genes Dev       Date:  2013-04-15       Impact factor: 12.890

Review 10.  What do we know about IDH1/2 mutations so far, and how do we use it?

Authors:  Craig Horbinski
Journal:  Acta Neuropathol       Date:  2013-03-20       Impact factor: 15.887

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.